Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polska Grupa HutniczaWAR:PGH +8.77%31 Gross Margin % is 65.71% as of Mar. 2026, which is 39% above its 10-year median of 47.28. GuruFocus rates WAR:PGH with a GF Score™ of 31/100 and a GF Value™ of zł0.31 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 942 Drug Manufacturers companies, Polska Grupa Hutnicza ranks better than 58.17% on this metric.
WAR:PGH's Gross Margin % is ranked better than 58.17% of 942
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs WAR:PGH: 53.30
Polska Grupa Hutnicza had a gross margin of 65.71% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Polska Grupa Hutnicza was 0.00% per year.
Polska Grupa Hutnicza (WAR:PGH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Polska Grupa Hutnicza had a gross margin of 65.71% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Polska Grupa Hutnicza Gross Margin % Related Terms
Polska Grupa Hutnicza Gross Margin % Historical Data
* Premium members only.
The historical data trend for Polska Grupa Hutnicza's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:PGH vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Polska Grupa Hutnicza's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polska Grupa Hutnicza Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Polska Grupa Hutnicza's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Polska Grupa Hutnicza's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Polska Grupa Hutnicza (WAR:PGH) has a Gross Margin % of 65.71% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Polska Grupa Hutnicza and its competitors. This is 39% above median its historical median of 47.28. According to the industry distribution chart, Polska Grupa Hutnicza ranks #394 out of 942 companies in the Drug Manufacturers industry, placing it in the top 41.8%.
Is Polska Grupa Hutnicza's Gross Margin % too high?
Polska Grupa Hutnicza's current Gross Margin % of 65.71% is 39% above median its 10-year median of 47.28. The Drug Manufacturers industry median Gross Margin % is 48.54. Polska Grupa Hutnicza's value of 65.71% is 35.4% above this industry median. Based on the distribution chart, Polska Grupa Hutnicza ranks #394 out of 942 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Polska Grupa Hutnicza has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Polska Grupa Hutnicza's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Polska Grupa Hutnicza ranks #394 out of 942 companies for Gross Margin %. This puts Polska Grupa Hutnicza in the upper half of its industry. The industry median Gross Margin % is 48.54. Polska Grupa Hutnicza's value of 65.71% is 35.4% above this benchmark. While the company's 10-year median is 47.28 vs. the industry median of 48.54, Polska Grupa Hutnicza has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polska Grupa Hutnicza's current Gross Margin % of 65.71% is 35.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Polska Grupa Hutnicza and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polska Grupa Hutnicza's current Gross Margin % is 65.71%, which is 39% above median its own 10-year median of 47.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polska Grupa Hutnicza stock overvalued right now?
Based on GuruFocus' analysis, Polska Grupa Hutnicza (WAR:PGH) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.31, compared to a current price of zł3.97 — trading 1180.6% above its estimated fair value. The current Gross Margin % is 65.71%, which is 39% above median its 10-year median of 47.28 and 35.4% above the Drug Manufacturers industry median of 48.54. Polska Grupa Hutnicza's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Polska Grupa Hutnicza (WAR:PGH), the current Gross Margin % is 65.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polska Grupa Hutnicza (WAR:PGH) Overvalued in 2026?
Based on GuruFocus' analysis, Polska Grupa Hutnicza stock appears to be overvalued.
The current stock price of zł3.97 is trading 1180.6% above its estimated GF Value™ of zł0.31.
GuruFocus considers Polska Grupa Hutnicza to be Significantly Overvalued.
Key valuation signals for WAR:PGH:
Gross Margin %: 65.71% (39% above median its 10-year median of 47.28)
GF Value™: zł0.31 vs. price of zł3.97 (1180.6% above fair value)
Industry Position: 35.4% above the Drug Manufacturers median (#394 of 942)
No single metric tells the full story. See the WAR:PGH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemp & Health SA is engaged in hemp and cannabis cultivation. The company processes harvested crops such as CBD and CBG, used for the production of white labels and private labels oils, creams, dried herbs and liquids for vaporization.
31GF Score
Get the complete analysis for WAR:PGH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PGH has been successfully added to your 
